This article is more than 5 years old. Information may no longer be current.
Outset appoints new chief medical officer, operations manager
Click Here to Manage Email Alerts
Dialysis machine manufacturer Outset Medical has appointed Michael Aragon, MD, as the company’s chief medical officer and Stacey Porter as vice president of people operations.
In a press release, the company said the expansion of its leadership “will help strengthen global operations and clinical efforts” for its Tablo dialysis machine.
Aragon is a board-certified internist and nephrologist who previously spent 14 years in clinical practice and as a medical director for DaVita and U.S. Renal Care, the company said. He was also the founding partner and president of North Texas Kidney Consultants and served as the medical director of acute hospital dialysis programs with Texas Health Resources Harris Fort Worth, a 660-bed hospital providing more than 700 dialysis treatments per month. He is currently chairman of the board of directors for the End-Stage Renal Disease (ESRD) Network of Texas.
“The leadership team at Outset is dedicated to improving care for patients with end-stage kidney disease with a simplified, more cost-effective dialysis solution,” Aragon said in the release. “Having served hundreds of patients firsthand for more than a decade, I’ve seen the burden of dialysis on patients, their families and their health care providers. I share Outset’s passion for bringing much-needed innovation to the industry, and look forward to helping lead the organization as it transforms the dialysis experience.”
Outset said Porter brings more than 18 years of leadership development and organizational learning implementation in the technology, pharmaceutical and medical device industries. Prior to joining Outset, she served as the head of global talent development for Intuitive Surgical, where she led enterprise talent management and organization development. Previously, Porter held leadership roles at VMware and Roche. She is completing a PhD in industrial/organizational psychology and holds a master’s degree in clinical social work.
“We are thrilled to welcome Michael and Stacey to the Outset Medical team,” said company CEO Leslie Trigg. “Both are outstanding leaders and experts in their fields, and will play an instrumental role in helping us deliver on our mission to improve global dialysis care and offer a better experience for providers and patients.”
Outset’s Tablo System is CE marked and FDA cleared for use in acute and chronic care settings. The company is conducting a clinical trial exploring Tablo for in-home use.
Reference: